They found that their PEG-coated AuNPs functionalized with pan-bombesin had very good optical stability when introduced into blood serum, and, by performing appropriate binding studies, they have evidenced that their conjugate could selectively target breast cancer tumor tissue (T47D cell line). The gene discussed is GRP; the disease is breast carcinoma.